These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 31689561)

  • 1. Assessment of candidate biomarkers in paired saliva and plasma samples from oral cancer patients by targeted mass spectrometry.
    Chi LM; Hsiao YC; Chien KY; Chen SF; Chuang YN; Lin SY; Wang WS; Chang IY; Yang C; Chu LJ; Chiang WF; Chien CY; Chang YS; Chang KP; Yu JS
    J Proteomics; 2020 Jan; 211():103571. PubMed ID: 31689561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a Multiplexed Assay for Oral Cancer Candidate Biomarkers Using Peptide Immunoaffinity Enrichment and Targeted Mass Spectrometry.
    Hsiao YC; Chi LM; Chien KY; Chiang WF; Chen SF; Chuang YN; Lin SY; Wu CC; Chang YT; Chu LJ; Chen YT; Chia SL; Chien CY; Chang KP; Chang YS; Yu JS
    Mol Cell Proteomics; 2017 Oct; 16(10):1829-1849. PubMed ID: 28821604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a Multiplexed Liquid Chromatography Multiple-Reaction-Monitoring Mass Spectrometry (LC-MRM/MS) Method for Evaluation of Salivary Proteins as Oral Cancer Biomarkers.
    Chen YT; Chen HW; Wu CF; Chu LJ; Chiang WF; Wu CC; Yu JS; Tsai CH; Liang KH; Chang YS; Wu M; Ou Yang WT
    Mol Cell Proteomics; 2017 May; 16(5):799-811. PubMed ID: 28235782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An immuno-MALDI mass spectrometry assay for the oral cancer biomarker, matrix metalloproteinase-1, in dried saliva spot samples.
    Hsiao YC; Lin SY; Chien KY; Chen SF; Wu CC; Chang YT; Chi LM; Chu LJ; Chiang WF; Chien CY; Chang KP; Chang YS; Yu JS
    Anal Chim Acta; 2020 Mar; 1100():118-130. PubMed ID: 31987131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salivary proteins from dysplastic leukoplakia and oral squamous cell carcinoma and their potential for early detection.
    Sivadasan P; Gupta MK; Sathe G; Sudheendra HV; Sunny SP; Renu D; Hari PS; Gowda H; Suresh A; Kuriakose MA; Sirdeshmukh R
    J Proteomics; 2020 Feb; 212():103574. PubMed ID: 31706945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic identification of salivary transferrin as a biomarker for early detection of oral cancer.
    Jou YJ; Lin CD; Lai CH; Chen CH; Kao JY; Chen SY; Tsai MH; Huang SH; Lin CW
    Anal Chim Acta; 2010 Nov; 681(1-2):41-8. PubMed ID: 21035601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A targeted proteomic strategy for the measurement of oral cancer candidate biomarkers in human saliva.
    Kawahara R; Bollinger JG; Rivera C; Ribeiro AC; Brandão TB; Paes Leme AF; MacCoss MJ
    Proteomics; 2016 Jan; 16(1):159-73. PubMed ID: 26552850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Salivary Proteomic Biomarkers for Oral Cancer Screening.
    Ishikawa S; Ishizawa K; Tanaka A; Kimura H; Kitabatake K; Sugano A; Edamatsu K; Ueda S; Iino M
    In Vivo; 2021; 35(1):541-547. PubMed ID: 33402507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A lectin-coupled, targeted proteomic mass spectrometry (MRM MS) platform for identification of multiple liver cancer biomarkers in human plasma.
    Ahn YH; Shin PM; Oh NR; Park GW; Kim H; Yoo JS
    J Proteomics; 2012 Sep; 75(17):5507-15. PubMed ID: 22789673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variability Assessment of 90 Salivary Proteins in Intraday and Interday Samples from Healthy Donors by Multiple Reaction Monitoring-Mass Spectrometry.
    Hsiao YC; Chu LJ; Chen YT; Chi LM; Chien KY; Chiang WF; Chang YT; Chen SF; Wang WS; Chuang YN; Lin SY; Chien CY; Chang KP; Chang YS; Yu JS
    Proteomics Clin Appl; 2018 Mar; 12(2):. PubMed ID: 29350471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MRM validation of targeted nonglycosylated peptides from N-glycoprotein biomarkers using direct trypsin digestion of undepleted human plasma.
    Lee JY; Kim JY; Cheon MH; Park GW; Ahn YH; Moon MH; Yoo JS
    J Proteomics; 2014 Feb; 98():206-17. PubMed ID: 24434586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of novel plasma protein biomarkers to predict imminent cystic fibrosis pulmonary exacerbations using multiple reaction monitoring mass spectrometry.
    Quon BS; Dai DL; Hollander Z; Ng RT; Tebbutt SJ; Man SF; Wilcox PG; Sin DD
    Thorax; 2016 Mar; 71(3):216-22. PubMed ID: 25777587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developing multiplexed assays for troponin I and interleukin-33 in plasma by peptide immunoaffinity enrichment and targeted mass spectrometry.
    Kuhn E; Addona T; Keshishian H; Burgess M; Mani DR; Lee RT; Sabatine MS; Gerszten RE; Carr SA
    Clin Chem; 2009 Jun; 55(6):1108-17. PubMed ID: 19372185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. iTRAQ-based quantitative analysis of age-specific variations in salivary proteome of caries-susceptible individuals.
    Wang K; Wang X; Zheng S; Niu Y; Zheng W; Qin X; Li Z; Luo J; Jiang W; Zhou X; Li W; Zhang L
    J Transl Med; 2018 Oct; 16(1):293. PubMed ID: 30359274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-throughput screening of saliva for early detection of oral cancer: a pilot study.
    Szanto I; Mark L; Bona A; Maasz G; Sandor B; Gelencser G; Turi Z; Gallyas F
    Technol Cancer Res Treat; 2012 Apr; 11(2):181-8. PubMed ID: 22335413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absolute quantification of 35 plasma biomarkers in human saliva using targeted MS.
    Hirtz C; Vialaret J; Nowak N; Gabelle A; Deville de Périère D; Lehmann S
    Bioanalysis; 2016; 8(1):43-53. PubMed ID: 26647646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery and preclinical validation of proteomic biomarkers in saliva for early detection of oral squamous cell carcinomas.
    Shan J; Sun Z; Yang J; Xu J; Shi W; Wu Y; Fan Y; Li H
    Oral Dis; 2019 Jan; 25(1):97-107. PubMed ID: 30169911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of salivary metabolomic biomarkers for oral cancer screening.
    Ishikawa S; Sugimoto M; Kitabatake K; Sugano A; Nakamura M; Kaneko M; Ota S; Hiwatari K; Enomoto A; Soga T; Tomita M; Iino M
    Sci Rep; 2016 Aug; 6():31520. PubMed ID: 27539254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of timing of collection of salivary metabolomic biomarkers on oral cancer detection.
    Ishikawa S; Sugimoto M; Kitabatake K; Tu M; Sugano A; Yamamori I; Iba A; Yusa K; Kaneko M; Ota S; Hiwatari K; Enomoto A; Masaru T; Iino M
    Amino Acids; 2017 Apr; 49(4):761-770. PubMed ID: 28101653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative proteomic analysis of microdissected oral epithelium for cancer biomarker discovery.
    Xiao H; Langerman A; Zhang Y; Khalid O; Hu S; Cao CX; Lingen MW; Wong DTW
    Oral Oncol; 2015 Nov; 51(11):1011-1019. PubMed ID: 26321370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.